Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rauen

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|August 16, 2016
Cold shock protein YB-1 is involved in hypoxia-dependent gene transcriptionThomas Rauen, Bjoern C Frye, Jialin Wang, et al.
Rheumatology International|December 24, 2024
Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohortStefan Krämer, Kristian Vogt, Theresa Maria Schreibing, et al.
The Journal of Biological Chemistry|July 16, 2011
A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosusThomas Rauen, Konrad Benedyk, Yuang-Taung Juang, et al.
Journal of Nephrology|September 15, 2022
Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational studyClaudia Seikrit, Judith I Schimpf, Stephanie Wied, et al.
The Journal of Biological Chemistry|September 20, 2013
cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and diseaseChristian M Hedrich, Thomas Rauen, Jose C Crispin, et al.
The Journal of Biological Chemistry|November 6, 2012
cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE)Thomas Rauen, Alexandros P Grammatikos, Christian M Hedrich, et al.
Journal of Nephrology|March 16, 2026
Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteriaStefan Krämer, Kristian Vogt, Martin Busch, et al.
Rheumatology International|December 2, 2025
Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patternsKristian Vogt, Stefan Krämer, Teresa Maria Schreibing, et al.
BMC Nephrology|November 21, 2018
Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)Judith Isabel Schimpf, Till Klein, Christina Fitzner, et al.
The Journal of Biological Chemistry|June 21, 2014
Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiationChristina Alidousty, Thomas Rauen, Lydia Hanssen, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|August 16, 2016
Cold shock protein YB-1 is involved in hypoxia-dependent gene transcriptionThomas Rauen, Bjoern C Frye, Jialin Wang, et al.
Rheumatology International|December 24, 2024
Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohortStefan Krämer, Kristian Vogt, Theresa Maria Schreibing, et al.
The Journal of Biological Chemistry|July 16, 2011
A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosusThomas Rauen, Konrad Benedyk, Yuang-Taung Juang, et al.
Journal of Nephrology|September 15, 2022
Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational studyClaudia Seikrit, Judith I Schimpf, Stephanie Wied, et al.
The Journal of Biological Chemistry|September 20, 2013
cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and diseaseChristian M Hedrich, Thomas Rauen, Jose C Crispin, et al.
The Journal of Biological Chemistry|November 6, 2012
cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE)Thomas Rauen, Alexandros P Grammatikos, Christian M Hedrich, et al.
Journal of Nephrology|March 16, 2026
Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteriaStefan Krämer, Kristian Vogt, Martin Busch, et al.
Rheumatology International|December 2, 2025
Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patternsKristian Vogt, Stefan Krämer, Teresa Maria Schreibing, et al.
BMC Nephrology|November 21, 2018
Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)Judith Isabel Schimpf, Till Klein, Christina Fitzner, et al.
The Journal of Biological Chemistry|June 21, 2014
Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiationChristina Alidousty, Thomas Rauen, Lydia Hanssen, et al.
Pageof 9